Autobio Diagnostics Co (SHSE:603658) Other Stockholders Equity: ¥296 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603658 Autobio Diagnostics Co Ltd SHSE:603658
95 GF Score
Price ¥32.83
GF Value ¥40.43
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Autobio Diagnostics Co Other Stockholders Equity?

Autobio Diagnostics Co SHSE:603658 -1.74% 95 Other Stockholders Equity is ¥296 Mil as of Jun. 2026. GuruFocus rates SHSE:603658 with a GF Score™ of 95/100 and a GF Value™ of ¥40.43 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Autobio Diagnostics Co's Other Stockholders Equity for the quarter that ended in Jun. 2026 was ¥296 Mil.

Autobio Diagnostics Co's quarterly Other Stockholders Equity increased from Dec. 2025 (¥296 Mil) to Mar. 2026 (¥3,623 Mil) but then declined from Mar. 2026 (¥3,623 Mil) to Jun. 2026 (¥296 Mil).

Autobio Diagnostics Co's annual Other Stockholders Equity increased from Dec. 2023 (¥297 Mil) to Dec. 2024 (¥297 Mil) but then declined from Dec. 2024 (¥297 Mil) to Dec. 2025 (¥296 Mil).

Autobio Diagnostics Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Autobio Diagnostics Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Autobio Diagnostics Co Other Stockholders Equity Chart

Autobio Diagnostics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 295.62 296.30 296.54 296.64 296.45

Autobio Diagnostics Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 296.64 3,652.34 296.45 3,623.33 296.12
SHSE:603658
95GF Score
Autobio Diagnostics Co Ltd SHSE:603658
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Autobio Diagnostics Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ¥296 Mil mean?
Autobio Diagnostics Co (SHSE:603658) has a Other Stockholders Equity of ¥296 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Autobio Diagnostics Co and its competitors.
Is Autobio Diagnostics Co's Other Stockholders Equity too high?
Autobio Diagnostics Co's current Other Stockholders Equity is ¥296 Mil. Overall, Autobio Diagnostics Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Autobio Diagnostics Co's Other Stockholders Equity compare to ABT and SYK?
Autobio Diagnostics Co's Other Stockholders Equity of ¥296 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Autobio Diagnostics Co and its competitors. Autobio Diagnostics Co's current Other Stockholders Equity is ¥296 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Autobio Diagnostics Co stock overvalued right now?
Based on GuruFocus' analysis, Autobio Diagnostics Co (SHSE:603658) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥40.43, compared to a current price of ¥32.83 — trading 18.8% below its estimated fair value. The current Other Stockholders Equity is ¥296 Mil. Autobio Diagnostics Co's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Autobio Diagnostics Co (SHSE:603658), the current Other Stockholders Equity is ¥296 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Autobio Diagnostics Co (SHSE:603658) Overvalued in 2026?

Based on GuruFocus' analysis, Autobio Diagnostics Co stock appears to be undervalued. The current stock price of ¥32.83 is trading 18.8% below its estimated GF Value™ of ¥40.43. GuruFocus considers Autobio Diagnostics Co to be Modestly Undervalued.

Key valuation signals for SHSE:603658:

  • Other Stockholders Equity: ¥296 Mil
  • GF Value™: ¥40.43 vs. price of ¥32.83 (18.8% below fair value)
  • GF Score™: 95/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603658 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Autobio Diagnostics Co Business Description

Address No. 199, Jingkai 15th Street, Economic and Technological Development Zone, Zhengzhou, CHN, 450016
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, and sales of in vitro diagnostic reagents and instruments. The company's main products include immunoassay, microbiological, molecular diagnostic, and biochemical reagents, along with immunoassay, microbiological, molecular detection, and mass spectrometry instruments, as well as auxiliary testing devices.
95GF Score

Get the complete analysis for SHSE:603658

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥32.83
Price
¥40.43
GF Value